Published in Acta Diabetol Lat on January 20, 1982
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia (2010) 4.33
Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care (2001) 2.11
Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab (1992) 1.62
Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab (2000) 1.45
Glucagon secretion in diabetic patients with idiopathic haemochromatosis. Diabetologia (1977) 1.42
Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemiol Ment Health (2006) 1.33
Magnesium and glucose homeostasis. Diabetologia (1990) 1.19
Presence of pancreatic glucagon in the portal plasma of human neonates. Differences in the insulin and glucagon responses to glucose between normal infants and infants from diabetic mothers. Diabetologia (1972) 1.15
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care (1991) 1.12
The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study. Int J Obes Relat Metab Disord (2001) 1.06
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study. Eur J Clin Pharmacol (1986) 1.05
Factors controlling gastric-glucagon release. J Clin Invest (1977) 1.02
IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia (1997) 1.00
Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc Soc Exp Biol Med (1970) 0.98
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia (1983) 0.98
Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study. Fertil Steril (1986) 0.96
Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab (1994) 0.95
Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis (2011) 0.94
Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience. Diabet Med (2008) 0.94
Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study. Obes Res (1996) 0.94
Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs. J Vet Pharmacol Ther (2010) 0.93
Growth hormone, cortisol, and glucagon concentrations during plasma free fatty acid depression: different effects of nicotinic acid and an adenosine derivative (BM 11.189). J Clin Endocrinol Metab (1983) 0.93
Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia (1986) 0.93
Age- and body mass index-related changes in cutaneous shear wave velocity. Exp Gerontol (2001) 0.93
Mechanisms involved in the exercise-induced increase in glucagon secretion in rats. Diabetes (1974) 0.92
Plasma glucagon levels in normal women during pregnancy. Diabetologia (1975) 0.90
Catecholamines and exercise-induced glucagon and fatty acid mobilization in the rat. Am J Physiol (1975) 0.89
Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects. Diabetologia (1996) 0.88
Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog. Metabolism (1975) 0.88
Letter: Potentiation of hypoglycemic effect of sulfonylureas by clofibrate. N Engl J Med (1976) 0.88
Glucagon and diabetes: a reappraisal. Diabetologia (1979) 0.88
Effects of pulsatile delivery of insulin and glucagon in humans. Am J Physiol (1989) 0.88
Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. Endocrinology (1978) 0.87
Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Diabetes Care (1984) 0.87
Insulin sensitivity, clearance and release in kininogen-deficient rats. Exp Physiol (1999) 0.87
Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes. J Clin Endocrinol Metab (1988) 0.86
Effect of dog jejunum "glucagon-like immunoreactive material" on adipose tissue metabolism. Horm Metab Res (1969) 0.86
Renal handling of endogenous glucagon in the dog: comparison with insulin. Metabolism (1974) 0.86
Biological properties of a transplantable islet-cell tumor of the golden hamster. 3. Electron microscopic studies. Diabetes (1968) 0.86
Belgian consensus on metabolic problems associated with atypical antipsychotics. Int J Psychiatry Clin Pract (2005) 0.86
The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabete Metab (1988) 0.86
A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism. Contraception (2003) 0.84
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin. Diabetologia (1983) 0.84
Biological properties of a transplantable islet-cell tumor of the golden hamster. II. Insulin content of the tumor and some metabolic characteristics of the tumor-bearing animals. Diabetes (1967) 0.84
Metabolic adaptations in post-exercise recovery. Clin Physiol (1982) 0.84
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Lond) (1991) 0.84
Fate of exogenous glucose during exercise of different intensities in humans. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.83
Plasma glucagon after kidney exclusion: experiments in somatostatin-infused and in eviscerated dogs. Metabolism (1976) 0.83
Muscular exercise and pancreatic function in rats. Isr J Med Sci (1972) 0.83
[Stimulation by carbamylcholine of dog gastric-glucagon release (author's transl) (proceedings)]. Ann Endocrinol (Paris) (1979) 0.82
Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab (1998) 0.82
Stimulation of insulin secretion after prostaglandin PGE 1 in the anesthetized dog. Biochem Pharmacol (1973) 0.82
Effect of oleic acid on insulin secretion by the isolated perfused rat pancreas. Diabetologia (1979) 0.82
Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man. Diabetes (1984) 0.82
Amputations in diabetic patients: a plea for footsparing surgery. Acta Chir Belg (2001) 0.82
Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes. Diabete Metab (1995) 0.81
Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative atorvastatin diabetes study in the belgian population. Clin Drug Investig (2010) 0.81
Angioplastic necrolytic migratory erythema. Unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptide. Am J Dermatopathol (1982) 0.81
[Skin diseases and obesity]. Rev Med Liege (2003) 0.81
[Rapid method for the determination of salicylates in blood]. Pharm Acta Helv (1971) 0.81
Independance of glucagon and insulin handling by the isolated perfused dog kidney. Diabetologia (1976) 0.80
Critical analysis of the "anaerobic threshold" during exercise at constant workloads. Eur J Appl Physiol Occup Physiol (1981) 0.80
Lipids and lipoproteins in chronic uraemia. A study of the influence of regular haemodialysis. Eur J Clin Invest (1976) 0.80
Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric (1999) 0.80
Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes. Diabetes Metab Res Rev (2001) 0.80
Insulin oscillations per se do not affect glucose turnover parameters in normal man. J Clin Endocrinol Metab (1986) 0.80
Metabolic adaptation to prolonged exercise in severely obese subjects. Int J Obes (1983) 0.80
Effect of protein-supplemented fasting on metabolic and hormonal responses to epinephrine infusion in obese subjects. Horm Metab Res (1982) 0.80
Effect of insulin on glucagon enhanced lipolysis in vitro. Diabetologia (1969) 0.79
[Bronchial reactivity in diabetic patients]. Rev Mal Respir (1997) 0.79
Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus (1993) 0.79
Cardiovascular effects of intravenous tolmesoxide in hypertensive patients. Arch Int Pharmacodyn Ther (1981) 0.79